High5 with Dr. Igor Grant, MD
High5 with Dr. Igor Grant, MD
Podcast Description
Welcome to High5 with Dr. Igor Grant, Distinguished Professor of Psychiatry and Director of the Center for Medicinal Cannabis Research at UC San Diego. Each month, we’ll take you on a fascinating journey into the evolving world of medicinal cannabis. From groundbreaking research to candid conversations with top scientists and clinicians across the globe. In each episode, Dr. Grant poses five thought-provoking questions to his guest, uncovering their personal journey and unique contributions to the field of medicinal cannabis.
Podcast Insights
Content Themes
The podcast delves into various topics surrounding medicinal cannabis, including its impact on pain management, the role of neuroimaging in understanding substance use, and cardiovascular risks associated with cannabis use, with specific episodes discussing the Cannabis Act in Canada and its implications for the U.S. as well as the relationship between cannabis and driving impairment.
Welcome to High5 with Dr. Igor Grant, Distinguished Professor of Psychiatry and Director of the Center for Medicinal Cannabis Research at UC San Diego. Each month, we’ll take you on a fascinating journey into the evolving world of medicinal cannabis. From groundbreaking research to candid conversations with top scientists and clinicians across the globe. In each episode, Dr. Grant poses five thought-provoking questions to his guest, uncovering their personal journey and unique contributions to the field of medicinal cannabis.
In episode 5, Dr. Grant speaks with Dr. Mark Ware as he discusses the evolution of cannabis use in pain management, the implications of the Cannabis Act in Canada, and the differences in cannabis policies between Canada and the U.S. Dr. Ware highlights the importance of understanding the psychoactive effects of cannabis, the challenges in medical research, and the need for a cohesive regulatory framework to ensure safety and efficacy in cannabis products.
Bio
Mark A. Ware, MD, MBBS, MSc, MRCP
Dr. Ware is an Associate Professor of Family Medicine and holds the Alan Edwards Chair in Clinical Pain at McGill University. He is also the Director of the interdisciplinary Alan Edwards Pain Management Unit at Montreal General Hospital.
He was a co-founder of the non-profit Canadian Consortium for the Investigation of Cannabinoids and served as Executive Director from2007 to 2018. Dr. Ware has advised the Canadian federal government on cannabis policy since 2001, and in 2016, he served as the vice-chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada. The task force’s report became Canadian law as the Cannabis Act in October 2018.
Takeaways
- Patients reported that cannabis helped their pain.
- The Cannabis Act was developed to allow for legalization and regulation.
- Cannabis is not covered under most provincial drug frameworks.
- The sky didn't fall after legalization; no major public health issues arose.
- The consumer has become a lot more educated about cannabis products.
- There is a patchwork of cannabis regulations in the U.S.
- The industry didn't pick up on medical research as hoped after legalization.
- A federal strong policy would be a game changer for cannabis regulation.
- The psychoactive effects of cannabis can play a role in pain management.
- The narrative around cannabis is slowly changing from prohibition to acceptance.
Chapters
00:00 High5 Introduction
01:09 Intro & background of Dr. Mark Ware
02:08 Early Research and Patient Experiences
05:38 Cannabis as an Analgesic
07:53 The Cannabis Act: Overview and Features
09:43 The Evolution of the Cannabis Act
10:34 Medical Use and Prescription Challenges
12:06 Insurance and Coverage for Cannabis
12:58 Patient Conversations and Treatment Frameworks
15:40 Post-Legalization Insights and Observations
19:21 Provincial Variations in Cannabis Regulation
21:16 Impact on Medical Research
24:25 GPP v. GMP
27:27 Lessons for the U.S. from Canada’s Experience
33:20 Outro
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.